The following section discusses preclinical findings on the most promising bioengineer approaches (Table 1) that have been developed to maximize the anticancer therapeutic potential of IL-10 by improving its tumor specificity and increasing its intratumoral concentrations [64]. Here, IL10 is linked to neoplasm.